{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:26:47Z","timestamp":1789712807384,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T00:00:00Z","timestamp":1248825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>There has emerged growing recognition of the link between housing and health. Since Vancouver, Canada has had increasing concerns with homelessness brought about by urban renewal in the lead-up to the 2010 Winter Olympic Games, we evaluated hepatitis C virus (HCV) incidence among injection drug users (IDU) with and without stable housing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data were derived from a collaboration between two prospective cohort studies of IDU in Vancouver, Canada. Using Cox Proportional Hazards regression, we compared HCV incidence among participants with and without stable housing, and determined independent predictors of HCV incidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Overall, 3074 individuals were recruited between May 1996 and July 2007, among whom 2541 (82.7%) were baseline HCV-infected. Among the 533 (17.3%) individuals who were not HCV-infected at baseline, 147 tested HCV antibody-positive during follow-up, for an incidence density of 16.89 (95% confidence interval: 14.76 \u2013 19.32) per 100 person-years. In a multivariate Cox regression model, unstable housing remained independently associated with HCV infection (relative hazard = 1.47 (1.02 \u2013 2.13).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>HCV prevalence and incidence are high in this setting and were associated with unstable housing. Efforts to protect existing low-income housing and improve access to housing may help to reduce HCV incidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2458-9-270","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T18:15:34Z","timestamp":1248891334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting"],"prefix":"10.1186","volume":"9","author":[{"given":"Christina","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W","family":"Tyndall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio SG","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,29]]},"reference":[{"key":"1673_CR1","unstructured":"World Health Organization Hepatitis C Fact Sheet. [http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en]"},{"key":"1673_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.puhe.2008.01.014","volume":"122","author":"X Xia","year":"2008","unstructured":"Xia X, Luo J, Bai J, Yu R: Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health. 2008, 122: 990-1003. 10.1016\/j.puhe.2008.01.014.","journal-title":"Public Health"},{"key":"1673_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.drugpo.2007.04.004","volume":"18","author":"C Aceijas","year":"2007","unstructured":"Aceijas C, Rhodes T: Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007, 18: 352-358. 10.1016\/j.drugpo.2007.04.004.","journal-title":"Int J Drug Policy"},{"key":"1673_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1258\/095646207779949880","volume":"18","author":"E Roy","year":"2007","unstructured":"Roy E, Alary M, Morissette C, Leclerc P, Boudreau JF, Parent R, Rochefort J, Claessens C: High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. Int J STD AIDS. 2007, 18: 23-27. 10.1258\/095646207779949880.","journal-title":"Int J STD AIDS"},{"issue":"Suppl 3","key":"1673_CR5","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/01.aids.0000192066.86410.8c","volume":"19","author":"DC Des Jarlais","year":"2005","unstructured":"Des Jarlais DC, Perlis T, Arasteh K, Torian LV, Hagan H, Beatrice S, Smith L, Wethers J, Milliken J, Mildvan D, et al: Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990\u20132001. AIDS. 2005, 19 (Suppl 3): S20-25. 10.1097\/01.aids.0000192066.86410.8c.","journal-title":"AIDS"},{"issue":"Suppl 3","key":"1673_CR6","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1097\/01.aids.0000192090.61753.d4","volume":"19","author":"H Hagan","year":"2005","unstructured":"Hagan H, Thiede H, Des Jarlais DC: HIV\/hepatitis C virus co-infection in drug users: risk behavior and prevention. AIDS. 2005, 19 (Suppl 3): S199-207. 10.1097\/01.aids.0000192090.61753.d4.","journal-title":"AIDS"},{"key":"1673_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2288-8-62","volume":"8","author":"RK Stern","year":"2008","unstructured":"Stern RK, Hagan H, Lelutiu-Weinberger C, Des Jarlais D, Scheinmann R, Strauss S, Pouget ER, Flom P: The HCV Synthesis Project: scope, methodology, and preliminary results. BMC Med Res Methodol. 2008, 8: 62-10.1186\/1471-2288-8-62.","journal-title":"BMC Med Res Methodol"},{"key":"1673_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/aje\/155.7.645","volume":"155","author":"LE Thorpe","year":"2002","unstructured":"Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein RS: Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002, 155: 645-653. 10.1093\/aje\/155.7.645.","journal-title":"Am J Epidemiol"},{"key":"1673_CR9","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/j.1360-0443.2008.02306.x","volume":"103","author":"T Rhodes","year":"2008","unstructured":"Rhodes T, Treloar C: The social production of hepatitis C risk among injecting drug users: a qualitative synthesis. Addiction. 2008, 103: 1593-1603. 10.1111\/j.1360-0443.2008.02306.x.","journal-title":"Addiction"},{"key":"1673_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2524.2005.00552.x","volume":"13","author":"NM Wright","year":"2005","unstructured":"Wright NM, Tompkins CN, Jones L: Exploring risk perception and behaviour of homeless injecting drug users diagnosed with hepatitis C. Health Soc Care Community. 2005, 13: 75-83. 10.1111\/j.1365-2524.2005.00552.x.","journal-title":"Health Soc Care Community"},{"key":"1673_CR11","first-page":"889","volume":"165","author":"DM Patrick","year":"2001","unstructured":"Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML, Strathdee SA, Currie SL, Schechter MT, O'Shaughnessy MV: Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Cmaj. 2001, 165: 889-895.","journal-title":"Cmaj"},{"key":"1673_CR12","volume-title":"June 14 and 15, 2007 COHRE Expert Workshop on Protecting and Promoting Housing Rights in the Context of Mega Events","author":"D Eby","year":"2007","unstructured":"Eby D: Still waiting at the altar: Vancouver 2010's on-again, off-again, relationship with social sustainability. June 14 and 15, 2007 COHRE Expert Workshop on Protecting and Promoting Housing Rights in the Context of Mega Events. 2007, Geneva, Switzerland: Pivot Legal Society and Impact on Community Coalition"},{"key":"1673_CR13","doi-asserted-by":"publisher","first-page":"F59","DOI":"10.1097\/00002030-199708000-00001","volume":"11","author":"SA Strathdee","year":"1997","unstructured":"Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, Schechter MT, O'Shaughnessy MV: Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997, 11: F59-65. 10.1097\/00002030-199708000-00001.","journal-title":"AIDS"},{"issue":"1","key":"1673_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1477-7517-1-9","volume":"1","author":"E Wood","year":"2004","unstructured":"Wood E, Kerr T, Buchner C, Marsh DC, Montaner JS, Tyndall M: Methodology for Evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal. 2004, 1 (1): 9-10.1186\/1477-7517-1-9.","journal-title":"Harm Reduction Journal"},{"key":"1673_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0140-6736(05)66475-6","volume":"366","author":"T Kerr","year":"2005","unstructured":"Kerr T, Tyndall M, Li K, Montaner JS, Wood E: Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005, 366: 316-318. 10.1016\/S0140-6736(05)66475-6.","journal-title":"Lancet"},{"key":"1673_CR16","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1056\/NEJMc052939","volume":"354","author":"E Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Zhang R, Stoltz JA, Lai C, Montaner JS, Kerr T: Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med. 2006, 354: 2512-2514. 10.1056\/NEJMc052939.","journal-title":"N Engl J Med"},{"key":"1673_CR17","first-page":"19","volume":"168","author":"KJ Craib","year":"2003","unstructured":"Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, Heath K, Tyndall MW, O'Shaughnessy MV, Schechter MT: Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ. 2003, 168: 19-24.","journal-title":"CMAJ"},{"key":"1673_CR18","first-page":"894","volume":"166","author":"PM Spittal","year":"2002","unstructured":"Spittal PM, Craib KJ, Wood E, Laliberte N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT: Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ. 2002, 166: 894-899.","journal-title":"CMAJ"},{"key":"1673_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00126334-200207010-00010","volume":"30","author":"CL Miller","year":"2002","unstructured":"Miller CL, Spittal PM, LaLiberte N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT: Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr. 2002, 30: 335-341.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1673_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00002030-200304110-00014","volume":"17","author":"MW Tyndall","year":"2003","unstructured":"Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, Schechter MT: Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003, 17: 887-893. 10.1097\/00002030-200304110-00014.","journal-title":"AIDS"},{"key":"1673_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.healthplace.2004.10.004","volume":"12","author":"TA Corneil","year":"2006","unstructured":"Corneil TA, Kuyper LM, Shoveller J, Hogg RS, Li K, Spittal PM, Schechter MT, Wood E: Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place. 2006, 12: 79-85. 10.1016\/j.healthplace.2004.10.004.","journal-title":"Health Place"},{"key":"1673_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/BF02351499","volume":"76","author":"A Palepu","year":"1999","unstructured":"Palepu A, Strathdee SA, Hogg RS, Anis AH, Rae S, Cornelisse PG, Patrick DM, O'Shaughnessy MV, Schechter MT: The social determinants of emergency department and hospital use by injection drug users in Canada. J Urban Health. 1999, 76: 409-418. 10.1007\/BF02351499.","journal-title":"J Urban Health"},{"key":"1673_CR23","volume-title":"The Costs of Homelessness in British Columbia","author":"M Eberle","year":"2001","unstructured":"Eberle M, Kraus D, Pomeroy S, Hulchanski D: Homelessness \u2013 Cause and Effects. The Costs of Homelessness in British Columbia. 2001, Victoria: BC Ministry of Social Development and Economic Security, 3:"},{"key":"1673_CR24","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(98)07026-3","volume":"353","author":"DC Des Jarlais","year":"1999","unstructured":"Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, Shi Q, Hagan H, Friedman SR: Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999, 353: 1657-1661. 10.1016\/S0140-6736(98)07026-3.","journal-title":"Lancet"},{"key":"1673_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","volume":"51","author":"S Drake","year":"1998","unstructured":"Drake S: Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998, 51: 253-263. 10.1016\/S0376-8716(98)00028-3.","journal-title":"Drug Alcohol Depend"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-9-270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-9-270\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-9-270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-9-270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:23:03Z","timestamp":1630459383000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-9-270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1673"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-9-270","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,29]]},"assertion":[{"value":"3 February 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"270"}}